What performance period was tied to Kathryn W. Kyle’s Labcorp (LH) share award?

The share grant relates to a performance award granted February 7, 2023, covering a three-year period ending December 31, 2025. The Form 4 footnote explains that the 1,584 shares were acquired pursuant to this long-term performance-based compensation arrangement.

Labcorp (LH) CLO awarded 1,584 shares; 451 withheld for tax

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

LABCORP HOLDINGS INC. executive Kathryn W. Kyle, EVP and Chief Legal Officer, received a grant of 1,584 shares of common stock on March 26, 2026 pursuant to a performance award tied to a three-year period ending December 31, 2025. To cover tax withholding obligations, 451 shares were disposed of through stock withholding at $268.38 per share, leaving her with 4,575.4574 shares of common stock held directly after these transactions. These events reflect compensation-related share awards and associated tax withholding rather than open-market trading.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Kyle Kathryn W

Role EVP, Chief Legal Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,584	$0.00	--
Tax Withholding	Common Stock	451	$268.38	$121K

Holdings After Transaction: Common Stock — 5,026.457 shares (Direct)

Footnotes (1)

Shares acquired on March 26, 2026, pursuant to a performance award granted on February 7, 2023, relating to performance during the three-year period ended December 31, 2025. Stock withholding to satisfy tax withholding obligations.

Key Figures

Shares granted: 1,584 shares Shares withheld for tax: 451 shares Withholding share value: $268.38 per share +3 more

6 metrics

Shares granted 1,584 shares Performance award acquired March 26, 2026

Shares withheld for tax 451 shares Stock withholding to satisfy tax obligations

Withholding share value $268.38 per share Value used for tax-withholding disposition

Post-transaction holdings 4,575.4574 shares Common stock held directly after transactions

Transaction date March 26, 2026 Date of grant and tax withholding

Performance period end December 31, 2025 End of three-year performance period for award

Key Terms

performance award, stock withholding, tax withholding obligations, Grant, award, or other acquisition

4 terms

performance award financial

"pursuant to a performance award granted on February 7, 2023, relating to performance during the three-year period ended December 31, 2025"

stock withholding financial

"Stock withholding to satisfy tax withholding obligations."

tax withholding obligations financial

"Stock withholding to satisfy tax withholding obligations."

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Form 4 Insider Transactions: What Each Field Means →

03/30/2026 - 12:43 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kyle Kathryn W

(Last)

(First)

(Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON

NORTH CAROLINA

27215

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP, Chief Legal Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/26/2026		A⁽¹⁾		1,584	A	$0	5,026.4574	D
Common Stock	03/26/2026		F⁽²⁾		451	D	$268.38	4,575.4574	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Shares acquired on March 26, 2026, pursuant to a performance award granted on February 7, 2023, relating to performance during the three-year period ended December 31, 2025.

2. Stock withholding to satisfy tax withholding obligations.

	/s/ Kathryn W. Kyle	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Labcorp (LH) executive Kathryn W. Kyle report in this Form 4?

Kathryn W. Kyle reported receiving a grant of 1,584 Labcorp common shares as compensation, with 451 shares withheld to cover taxes. After these transactions, she directly held 4,575.4574 shares, according to the Form 4 filing.

Was the Labcorp (LH) Form 4 transaction an open-market trade?

The Form 4 does not show an open-market trade. It reports a compensation-related share grant and a tax-withholding disposition, where 451 shares were withheld at $268.38 per share to satisfy tax obligations rather than being sold in the market.

How many Labcorp (LH) shares were granted to Kathryn W. Kyle?

Kathryn W. Kyle was granted 1,584 shares of Labcorp common stock on March 26, 2026. The filing states these were acquired pursuant to a performance award granted February 7, 2023, tied to performance over a three-year period ending December 31, 2025.

Why were 451 Labcorp (LH) shares disposed of in Kathryn W. Kyle’s filing?

The 451 Labcorp shares were disposed of through stock withholding to satisfy tax withholding obligations. The Form 4 labels this as a tax-withholding disposition, with the shares valued at $268.38 each for this purpose rather than representing a discretionary sale.

How many Labcorp (LH) shares does Kathryn W. Kyle hold after the reported transactions?

Following the grant and tax-withholding disposition, Kathryn W. Kyle directly holds 4,575.4574 Labcorp common shares. The Form 4 specifies this post-transaction ownership figure, reflecting her remaining position after 451 shares were withheld for taxes.